HOME ¡Ã ºÇ¶á¤ÎÏÃÂê ¡Ã ¼¡²ó¤Î¸¦µæ²ñ ¡Ã ¸¦µæ²ñ¤ÎÊâ¤ß ¡Ã ÌòΩ¤Á¾ðÊó ¡Ã keywords ¡Ã °Õ¸«¸ò´¹ ¡Ã ¥ê¥ó¥¯

2009ǯ6·î13Æü(ÅÚ)

???????????????????????FDA?

Åê¹Æ¼Ô: ????????

??FDA?12????????????????????????????????????????????????????Zileuton ??????????????????????????????????????????????????????

FDA Requests Labeling Change for Leukotriene Modifiers
??FDA Press Annoucement 2009.6.12?
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm166293.htm

Updated Information on Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)(????)
?Postmarket Drug Safety Information for Patients and Providers 2009.6.12 Update?

?FDA????????????? post-market reports ?????????????????????????????????????????????????????????????????FDA?????????????????????????????????????????????????????????????????????????????????

?FDA?????????????????????????????????

  • ?????????????????????????????????????????????
  • ???????????????????????????????
  • ?????????????????????????????????????????

????????????????????????????2008?3?27??FDA?“Early Communication”?????????????????????????????????????????5???????????????????????????????????????????????????????????????????????????????????????????????????????

Follow-up to the March 27, 2008, Communication about the Ongoing Safety Review of Montelukast (Singulair)???????2009.1.13?

???????????????????Vol.7 No.4??????????
?http://www.nihs.go.jp/dig/sireport/weekly7/04090219.pdf

??????????????Vol.6 No.9
?http://www.nihs.go.jp/dig/sireport/weekly6/09080502.pdf

????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

?????
FDA says users of Singulair and similar meds should watch for such problems
?Health Day 2009.06.12?
?http://www.healthday.com/Article.asp?AID=628062

¢¬Top¤ËÌá¤ë¡¡¡¡

¥³¥á¥ó¥È (0)

¤³¤Îµ­»ö¤Ë¤Ï¤Þ¤À¥³¥á¥ó¥È¤¬¤Ä¤¤¤Æ¤¤¤Þ¤»¤ó¡£

¸½ºß¡¢¤³¤Îµ­»ö¤Ø¤Î¥³¥á¥ó¥È¤Ï夤¤Æ¤ª¤ê¤Þ¤»¤ó¡£

Copyright(C) Ryomo Apotheker Network, All rights reserved, since 2004